Hemas Holdings Ltd.

HHL.N0000Moderately undervalued

Diversified Holdings · Industrial Conglomerates · S&P SL20

Hemas Holdings PLC is a diversified Sri Lankan conglomerate with principal activities across consumer goods, healthcare, mobility, leisure, travel and aviation, and logistics and maritime services.

HHL shares are down 7.9% over the past year and last closed at Rs 32.80 on Nov 17, 2026.

Rs 32.80
+0.00%
as of Nov 17, 2026
Price history
-7.87%
P/E
11.4to Sep 26
P/B
1.71
NAV / Share
Rs 19.22
EPS
Rs 2.87to Sep 26
Profit Growth
-1.1%
Div Yield
3.05%
Market Cap
Rs 98.3B
Beta
0.69
ROE
15.0%
Op Margin
10.0% (-0.8pp)

Fundamentals

LineFY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue
Rs 127.4B
+8.0%
Rs 118.0B
-3.0%
Rs 121.6B
+6.7%
Rs 113.9B
+44.5%
Rs 78.8B
+22.2%
Rs 64.5B
+4.7%
Rs 61.6B
-3.8%
Rs 64.1B
+26.0%
Operating profit
Rs 14.1B
+3.2%
Rs 13.7B
+15.0%
Rs 11.9B
+8.7%
Rs 11.0B
+61.6%
Rs 6.8B
+11.9%
Rs 6.1B
+70.2%
Rs 3.6B
-37.1%
Rs 5.7B
+33.4%
Net profit
Rs 9.3B
+11.4%
Rs 8.3B
+31.2%
Rs 6.4B
+25.4%
Rs 5.1B
+4.8%
Rs 4.8B
+44.7%
Rs 3.3B
+145.3%
Rs 1.4B
-63.0%
Rs 3.7B
+24.7%
EPS
2.98
+10.4%
2.70
-73.6%
10.24
+43.0%
7.16
+0.6%
7.12
+30.4%
5.46
+163.8%
2.07
-63.4%
5.65
+20.7%

Compared with the same period a year earlier.

Per-share figures are as reported, not adjusted for splits.

Coming up

  • Dec 4, 2026Dividend paidFirst interim dividend, Rs 0.25 a shareAnnouncement
Ex-dateDividendPer share
Nov 16, 2026FY2027 · first interimRs 0.25
Jun 30, 2026FY2026 · finalRs 0.75
Nov 18, 2025FY2026 · first interimRs 0.25
Jun 26, 2025FY2025 · finalRs 0.70
Nov 18, 2024FY2025 · first interimRs 1.00
Jun 28, 2024FY2024 · finalRs 3.00
Nov 20, 2023FY2024 · first interimRs 0.40
Jul 4, 2023FY2023 · finalRs 1.95

Upcoming dividends, rights issues and splits across the CSE: dividend calendar →

Peer comparison7 peers in Diversified Holdings
P/E
18.6
P/B
0.81
ROE
4.31%
Yield
1.58%
MELS.N0000
P/E
11.7
P/B
1.39
ROE
11.91%
Yield
4.22%
HAYL.N0000
P/E
12.5
P/B
1.53
ROE
14.53%
Yield
2.56%
P/E
15.1
P/B
1.20
ROE
8.68%
Yield
1.82%
CTHR.N0000
P/E
14.2
P/B
2.90
ROE
20.36%
Yield
2.91%
VONE.N0000
P/E
7.5
P/B
0.85
ROE
11.29%
Yield
1.60%
HHL.N0000 · this company
P/E
11.4
P/B
1.71
ROE
14.95%
Yield
3.05%
BUKI.N0000
P/E
19.8
P/B
1.06
ROE
6.34%
Yield
2.35%
Peer median · 7 companies
P/E 14.2P/B 1.20Yield 2.35%

About Hemas Holdings Ltd.

Hemas Holdings PLC is a diversified Sri Lankan conglomerate with principal activities across consumer goods, healthcare, mobility, leisure, travel and aviation, and logistics and maritime services. The Group markets home and personal care and other consumer products domestically and in regional markets, and has a portfolio of businesses across pharmaceuticals, hospitals, hospitality and travel. The Healthcare vertical comprises pharmaceutical distribution and manufacturing (Morison), and a hospitals group operating facilities such as Wattala and Thalawathugoda; the Consumer vertical includes home and personal care categories and brands such as Atlas (including a 'Back to School' range). The Group also operates hotels and inbound travel businesses including Serendib Hotels (SHOT) and Anantara Peace Haven Tangalle, and maintains operations in Sri Lanka with regional presence in Bangladesh, West Bengal and Myanmar. Hemas positions itself as a national leader in consumer and healthcare solutions, seeking to develop brands, commercial partnerships and manufacturing capacity while engaging in route-to-market and regulatory initiatives relevant to its sectors.

AI analysis

bullish

Evidence points bullish: annual profit growth and a net-cash balance sheet support a moderately undervalued price. The latest quarter's profit slipped despite higher sales.

Read the full report (Nov 18, 2026) →

News sentiment

Describes news flow, not a forecast
Last 30 days
Most positive news flow in 4 months
its own lowits own high

Higher than 58% of its last 19 months · 7 of 11 in its sector

10 articles in 30 days: 6 positive, 1 negative, 3 neutral.

24 months positive negative 3-month net
Jan 25: 5 articles, net +0.20Feb 25: 3 articles, net +0.33Mar 25: 6 articles, net -0.13Apr 25: 5 articles, net +0.71May 25: 7 articles, net +1.00Jun 25: 4 articles, net +1.00Jul 25: 2 articles, net +0.17Aug 25: 3 articles, net +0.82Sep 25: 3 articles, net +0.71Oct 25: 3 articles, net +1.00Nov 25: 7 articles, net +0.10Dec 25: 7 articles, net +0.00Jan 26: 7 articles, net +0.74Feb 26: 2 articles, net +1.00Mar 26: 3 articles, net -0.20Apr 26: 1 articles, net +1.00May 26: 13 articles, net +0.38Jul 26: 4 articles, net +0.67Aug 26: 8 articles, net +0.31Sep 26: 6 articles, net -0.43Oct 26: 6 articles, net -0.67Nov 26: 9 articles, net +0.55Dec 24Apr 25Aug 25Dec 25Apr 26Aug 26
Recent news
View all news →
EconomyNext·Nov 11, 2026·Market commentary
Sri Lanka stocks close down 0.41-pct, banks lead turnover

Sri Lanka's CSE closed down 0.41% as the ASPI fell 90.46 points to 22,032.93, with market turnover of LKR 4.82 billion and the banking group leading turnover at LKR 1.18 billion. Notable movers included gains for Dialog, Distilleries, Ceylon Cold Stores, Aitken Spence and DFCC, while HNB, Overseas Realty, Commercial Bank, Hayleys and Carson Cumberbatch were laggards.

EconomyNext·Nov 11, 2026·Market commentaryPositive
Sri Lanka stocks trend lower; Materials lead turnover

Colombo Stock Exchange trended lower ahead of the National Budget: ASPI down 0.27% (60.10 pts) at 22,063.29, S&P SL20 down 0.28%, market turnover Rs 1.42bn with Materials leading turnover at Rs 354.73m. Top gainers included Dialog, Distilleries and Ceylon Cold Stores, while Singer, Carson Cumberbatch and Janashakthi were top decliners; dividends were announced by Dialog, Ceylon Grain Elevators and Three Acre Farms.

EconomyNext·Nov 10, 2026·Market commentary
Sri Lanka shares jump 2.75-pct on lower oil prices, US election tariff hopes

Colombo Stock Exchange's ASPI rose 2.75% to 22,123.39 on Tuesday, lifted by lower oil prices and hopes of US tariff adjustments. Top gainers included Vallibel One, Dialog Axiata, Commercial Bank, Hayleys and HNB; market turnover was 7.96 billion rupees, led by the banking sector.

ExportersFuel & Energy Prices
Ada Derana·Nov 6, 2026·Earnings & resultsPositive
Strong Q2 lifts Hemas H1 revenue to Rs. 66.6 Bn, up 9.5%, with EBITDA returning to YoY growth

Hemas Holdings (HHL.N0000) reported H1 FY27 revenue of Rs.66.6bn, up 9.5% YoY, driven by a strong Q2 (Rs.37.8bn, +17.0%) and EBITDA rebounding 10.5% YoY to Rs.4.5bn; group earnings fell 3.0% YoY due to higher finance costs from working-capital borrowings and the Twiga acquisition.

Consumer Staples (FMCG)Healthcare & Pharma
Daily FT·Nov 6, 2026·Earnings & resultsPositive
Strong 2Q lifts Hemas 1H revenue to Rs. 67 b, up 9.5%

Hemas Holdings reported 1H FY27 revenue of Rs. 67.0 billion, up 9.5% YoY, after a strong 2Q when revenue rose 17% YoY to Rs. 37.8 billion and EBITDA rebounded to Rs. 4.5 billion. All four segments grew and the group completed a 75% acquisition of East Africa's Twiga.

Consumer Staples (FMCG)Healthcare & Pharma
Daily FT·Oct 29, 2026·Market commentaryPositive
CSE sees strong rebound, on the up for second straight session

Colombo stocks rebounded for a second session as the ASPI rose 1.41% (277.55 pts) to 19,970.22 and the S&P SL20 gained 1.43%. Turnover was nearly Rs.2.2bn with foreign investors net sellers of Rs.894.3m; top contributors were COMB, DIAL, HNB, HHL and CIC, and telecoms led turnover with a 39% share.